JP2022514255A5
(https= )
2022-12-19
JP3311392B2
(ja )
2002-08-05
新規な経口活性エラスターゼ阻害剤
TW408133B
(en )
2000-10-11
Bradykinin antagonist peptides incorporating N-substituted glycines
JP4732438B2
(ja )
2011-07-27
上昇した血中尿素濃度を低減させるオリゴペプチド
JP2022517040A5
(https= )
2023-01-25
JP2022518695A5
(https= )
2023-01-25
HU181009B
(en )
1983-05-30
Process for preparing angiotensin-ii analogues with antagonictic activity containing in position 1 sarcosyl,hydroxyacetyl or l-alpha-aminoxy-propionyl group and in positiona 8 esteric group
JP2010501479A5
(https= )
2010-07-01
JP2006523214A5
(https= )
2007-05-10
JP2009510128A
(ja )
2009-03-12
ウイルス感染の治療及び予防のためのシクロスポリンaのアリールアルキル及びヘテロアリールアルキル誘導体
JP2002527354A5
(https= )
2006-05-18
JP2010209088A
(ja )
2010-09-24
P−セレクチンに対する結合性化合物
KR20180095809A
(ko )
2018-08-28
α4β7 인테그린을 표적으로 하는 고리형 펩타이드
SK11242002A3
(sk )
2003-06-03
Zlúčenina, spôsob prípravy zlúčeniny, farmaceutický prostriedok a spôsob liečenia rakoviny
JP2004509845A5
(https= )
2005-04-21
CA2140931A1
(en )
1994-01-27
Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune disease and tumour progression
JP2024515306A5
(https= )
2025-04-28
JPWO2023085402A5
(https= )
2025-11-19
CA3123368A1
(en )
2020-06-25
Mitochondria-targeting peptides
JP2006513141A5
(https= )
2006-08-17
JP2949129B2
(ja )
1999-09-13
胃腸運動刺激活性を有するモチリン類似ポリペプチド
US6399599B1
(en )
2002-06-04
Substituted 2-oxo-1,4-diazacycloalkanes
EP1635857A1
(en )
2006-03-22
TREATMENT OF HAEMORRHAGIC SHOCK USING COMPLEMENT 5a RECEPTOR INHIBITORS
WO2002024192A1
(fr )
2002-03-28
Ligands dipeptidiques du recepteur npff pour le traitement de la douleur et des hyperalgies
US20200230111A1
(en )
2020-07-23
Prodrugs of glutamine analogs